How many clinical trials are tracked for Benign Prostatic Hyperplasia?

55 trials are tracked, 1 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine Orthopedics & Sports Medicine OB/GYN & Women's Health Radiology & Imaging Genetics & Precision Medicine Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Urology Ophthalmology Dermatology Emergency Medicine Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Log in / Sign up

Benign Prostatic Hyperplasia

Part of Prostatic Diseases

14 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Benign Prostatic Hyperplasia

55 trials tracked for Benign Prostatic Hyperplasia: 22 in phase 3 or 4 and 1 with published results. The most-cited published study has 15 citations.

55Trials tracked

22Phase 3 & 4

0Recruiting

1With published results

Phase distribution

Phase 4 7 Phase 3 15 Phase 2 13 Phase 1 1 Other / NA 19

Phase 3 Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression Completed · 15 cited
Phase 4 A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS). Completed
Phase 4 A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) Completed
Phase 4 Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain Completed
Phase 4 Deprescribing Tamsulosin in Older Men Completed
Phase 4 TRADE-Testosterone Replacement and Dutasteride Effectiveness Completed

Show 44 more trials

Phase 4 A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization Completed
Phase 4 Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia Completed
Phase 3 A Comparison of Traditional and MOSES Laser Enucleation of the Prostate (MOLEP): A Prospective, Randomized, Double-blinded Control Trial A Comparison of Traditional and MOSES Laser Enucleation of the Prostate (MOLEP): A Prospective, Randomized, Double-blinded Control Trial Completed
Phase 3 Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH) Completed
Phase 3 Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH) Completed
Phase 3 A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers Completed
Phase 3 A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia Completed
Phase 3 Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily Completed
Phase 3 A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo Completed
Phase 3 A Study in Benign Prostatic Hyperplasia Completed
Phase 3 The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months Completed
Phase 3 Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms Completed
Phase 3 Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia Completed
Phase 3 A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms Completed
Phase 3 Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia Completed
Phase 3 Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms Completed
Phase 2 Botulinum Toxin Injection for the Management of BPH Completed
Phase 2 Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia Completed
Phase 2 Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With BPH and LUTS Completed
Phase 2 Prostate Embolization for Benign Prostatic Hyperplasia Completed
Phase 2 Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension Completed
Phase 2 Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels Completed
Phase 2 Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men Completed
Phase 2 Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter Completed
Phase 2 Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia Completed
Phase 2 A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia Completed
Phase 2 Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia Completed
Phase 2 Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia Completed
Phase 2 Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia Completed
Phase 1 A Study of Tadalafil in Benign Prostatic Hyperplasia Completed
N/A An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres Completed
N/A Anti-Androgen Treatment for COVID-19 Completed
N/A BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia Completed
N/A The Safety and Effectiveness of UroLift: LIFT Pivotal Study Completed
N/A Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia Completed
N/A Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate) Completed
N/A UroLift System TOlerability and ReCovery When Administering Local Anesthesia Completed
N/A Rezum I Pilot Study for Benign Prostatic Hyperplasia Completed
N/A Rezum FIM Optimization Study Completed
N/A Embosphere® PROstate Post Market Study Completed
N/A Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia Completed
N/A GreenLight XPS Laser System Retrospective Chart Review Completed
N/A Flexiva Pulse Registry Completed
N/A Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) Completed

Showing the 50 most-cited and recently-updated of 55 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

‹ Prev 1 2

Questions about Benign Prostatic Hyperplasia

What is the risk of developing bladder stones after prostate resection for BPH?

After prostate resection for BPH, the risk of developing bladder stones is low but increases with certain factors like larger prostate volume, higher symptom scores, and elevated uric acid.

Full answer →

Does ThuLEP surgery result in a shorter hospital stay compared to RASP for large BPH?

Yes, ThuLEP generally results in a shorter hospital stay than RASP for large BPH, though some studies show no difference.

Full answer →